Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 6.88 USD -3.91% Market Closed
Market Cap: 314.5m USD

Relative Value

The Relative Value of one CAPR stock under the Base Case scenario is 35.28 USD. Compared to the current market price of 6.88 USD, Capricor Therapeutics Inc is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAPR Relative Value
Base Case
35.28 USD
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
68
vs Industry
27
Median 3Y
18.6
Median 5Y
33.8
Industry
7.6
Forward
2.5
vs History
vs Industry
Median 3Y
-5.5
Median 5Y
-5.7
Industry
24.2
Forward
-7.1
vs History
vs Industry
8
Median 3Y
-5.8
Median 5Y
-6.9
Industry
20.3
vs History
vs Industry
3
Median 3Y
-5.4
Median 5Y
-5.9
Industry
22.9
vs History
85
vs Industry
10
Median 3Y
8.3
Median 5Y
4.6
Industry
2.9
vs History
69
vs Industry
24
Median 3Y
11.7
Median 5Y
27
Industry
7.9
Forward
1.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-4.9
Industry
5.1
Forward
-3.5
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4.8
Industry
5.1
Forward
-5.8
vs History
vs Industry
11
Median 3Y
-4.1
Median 5Y
-4.3
Industry
5.7
vs History
vs Industry
5
Median 3Y
-3.8
Median 5Y
-4
Industry
4.2
vs History
15
vs Industry
1
Median 3Y
31.1
Median 5Y
18.9
Industry
5.2

Multiples Across Competitors

CAPR Competitors Multiples
Capricor Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Capricor Therapeutics Inc
NASDAQ:CAPR
314.3m USD 18.1 -5.7 -3.1 -3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 159 077.2 -162 353 -197 148.4 -194 898.7
US
Abbvie Inc
NYSE:ABBV
334.3B USD 5.8 80.5 15.3 22.6
US
Amgen Inc
NASDAQ:AMGN
158.5B USD 4.6 26.7 14.4 23.7
US
Gilead Sciences Inc
NASDAQ:GILD
134.7B USD 4.7 22.6 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.2B USD 10.6 -119.5 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 062.4 -526.3 -573.1 -557.8
AU
CSL Ltd
ASX:CSL
124.6B AUD 5.3 29.5 18.1 22.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
58.7B USD 4.2 13 11.6 13.1
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -60.9 -65.7 -59.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.8B USD 17.8 -154.9 -694.7 -348.1
P/E Multiple
Earnings Growth PEG
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average P/E: 34.5
Negative Multiple: -5.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 353 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.7
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.6
189%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.5 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.3 N/A N/A
AU
CSL Ltd
ASX:CSL
29.5
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -154.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average EV/EBITDA: 15.8
Negative Multiple: -3.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 148.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -573.1 N/A N/A
AU
CSL Ltd
ASX:CSL
18.1
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.6
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -694.7 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average EV/EBIT: 20.4
Negative Multiple: -3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 898.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.6
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.7
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.8 N/A N/A
AU
CSL Ltd
ASX:CSL
22.7
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.1
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -348.1 N/A N/A